Skip to main contentAI and Advanced
/
EPIGRAL · NSEBSE SENSEX74,546.06+0.31%BSE |
NIFTY 5023,332.85+0.27%NSE |
NIFTY BANK56,341.2+0.51%NSE |
NIFTY IT28,671.45-1.66%NSE |
NIFTY AUTO27,231.2+0.27%NSE |
NIFTY FMCG45,695.45+0.27%NSE |
NIFTY PHARMA26,628.25+0.18%NSE |
NIFTY 50022,784+0.57%NSE |
EP
NSE · Equity shares · Chemical Manufacturing-3.10 · -0.28%
Epigral EPIGRAL
NSE:INR 1,098.3
BSE:INR 1,100
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceLast market snapshot
Company fundamentalsStale · last-known data
Research sections9 of 9 availableMissing source values remain unavailable, never zero-filled.
AI analysis and Advanced tools for EPIGRAL
Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Snapshot
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
Previous closeINR 1,101.4
Day rangeINR 1,077 — INR 1,115.9
52-week rangeINR 806.2 — INR 1,946.05
Volume23,453
Market cap4,649.98
P/E10.08
Fundamental highlightsReported values unless marked as computed
Revenue (INR Cr)2,527.18
Net Income (INR Cr)331.97
Rev Growth (5 Year %)24.99
EPS Growth (5 Year %)25.96
P/E Ratio10.08
EPS75.47
Research path: Interpret Epigral's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Validated OHLC
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
EPIGRALEpigral1d · INR · NSE
Loading validated candles…
Auditable calculations
Daily technical summary
Calculated from validated daily candles. Descriptive research only.
Calculating technicals…
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
Company reporting
Financial statements
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 3,505.3 | 3,152.44 | 2,794.34 |
| Accumulated Depreciation Total | -823.26 | -699.56 | -626.9 |
| Cash Equivalents | 5.44 | 22.18 | 6.79 |
| Other Liabilities Total | 19.45 | 9.18 | 4.88 |
| Accrued Expenses | 30.39 | 5.01 | 13.79 |
| Long Term Debt | 333.69 | 448.97 | 547.04 |
| Common Stock Total | 43.14 | 43.14 | 41.55 |
| Other Current Assets Total | 0 | 0.32 | 1.05 |
| Prepaid Expenses | 46.47 | 13.76 | 11.49 |
| Total Assets | 3,505.3 | 3,152.44 | 2,794.34 |
| Current Portof LT Debt/Capital Leases | 121.81 | 90.69 | 195.85 |
| Cash | 0.02 | 0.01 | 0.01 |
| Total Equity | 2,221.43 | 1,904.53 | 1,254.1 |
| Long Term Investments | 72.86 | 21.57 | 21.04 |
| Retained Earnings(Accumulated Deficit) | 2,178.29 | 1,861.39 | 1,212.55 |
| Total Common Shares Outstanding | 4.31 | 4.31 | 4.16 |
| Property/Plant/Equipment Total-Gross | 3,375.78 | 2,982.74 | 2,854.42 |
| Tangible Book Valueper Share Common Eq | 511.33 | 437.12 | 296.54 |
| Total Liabilities | 1,283.87 | 1,247.91 | 1,540.24 |
| Total Debt | 572.04 | 592.53 | 964.04 |
| Short Term Investments | 1.34 | 77.86 | Not available |
| Cashand Short Term Investments | 6.8 | 100.05 | 6.8 |
| Total Receivables Net | 424.79 | 273.12 | 219.6 |
| Notes Payable/Short Term Debt | 114.02 | 49.5 | 221.05 |
| Deferred Income Tax | 217.79 | 293.65 | 208.65 |
| Accounts Receivable-Trade Net | 416.53 | 232.32 | 178.75 |
| Property/Plant/Equipment Total-Net | 2,552.52 | 2,283.18 | 2,227.52 |
| Total Current Liabilities | 710.42 | 492.74 | 779.57 |
| Total Inventory | 348.63 | 387.99 | 262.99 |
| Accounts Payable | 259.7 | 185.68 | 165.28 |
| Other Currentliabilities Total | 184.5 | 161.86 | 183.6 |
| Total Long Term Debt | 336.21 | 452.34 | 547.14 |
| Intangibles Net | 15.5 | 18.73 | 21.96 |
| Other Long Term Assets Total | 6.92 | 7.27 | 8.07 |
| Note Receivable-Long Term | 30.81 | 46.45 | 13.82 |
| Total Current Assets | 826.69 | 775.24 | 501.93 |
| Capital Lease Obligations | 2.52 | 3.37 | 0.09 |
Fundamentals
Valuation and ratios
Growth
Debt 5Yr CAGR %1.08
Margins
Operating Margin 12m15.74
Operating Margin 5y Avg21.8
Net Profit Margin 12m10.32
Net Profit Margin 5y13.88
Yield
Dividend Yield %0.45
Valuation
Price to Sale Ratio1.84
Risk and consensus
Source-qualified signals
Risk metrics
Overall RiskHigh risk
Board Risk45.06
Analyst consensus
ConsensusStrong Buy
Consensus score1.00
Analyst opinions1
Strong Sell count0
Sell count0
Hold count0
Buy count0
Strong Buy count1
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Industry context
Peer comparison
Only peers present in the company profile payload are displayed.
| Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|
| Asian Paints | INR 2,749 | 2.64 L | 58.09 | — |
| Solar Industries India | INR 18,560 | 1.68 L | 99.61 | — |
| Pidilite Industries | INR 1,671 | 1.70 L | 64.76 | — |
| SRF | INR 2,626 | 77,841.16 | 44.57 | — |
| Linde India | INR 7,105 | 61,033.66 | 110.53 | — |
Shareholding
Ownership
- Promoter
- 68.83%
- FII
- 1.03%
- MF
- 5.52%
- Other
- 24.62%
Company intelligence
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Epigral Ltd is Rated Sell - Markets MojoMarket news · 3 Jun 2026, 10:11 am
Epigral Ltd is Rated Sell Markets Mojo
Epigral Ltd is Rated Sell - Markets MojoMarket news · 3 Jun 2026, 2:09 am
Epigral Ltd is Rated Sell Markets Mojo
Epigral Limited Fixes June 1 Record Date for 19th AGM, e-Voting and ₹5 Dividend - scanx.tradeMarket news · 1 Jun 2026, 12:30 pm
Epigral Limited Fixes June 1 Record Date for 19th AGM, e-Voting and ₹5 Dividend scanx.trade
Epigral Limited (NSE:EPIGRAL) Passed Our Checks, And It's About To Pay A ₹5.00 Dividend - simplywall.stMarket news · 28 May 2026, 6:05 am
Epigral Limited (NSE:EPIGRAL) Passed Our Checks, And It's About To Pay A ₹5.00 Dividend simplywall.st
Epigral Limited Annual Secretarial Compliance Report for FY 2025-26 Filed - InvestyWiseMarket news · 26 May 2026, 1:19 pm
Epigral Limited Annual Secretarial Compliance Report for FY 2025-26 Filed InvestyWise
Epigral Ltd is Rated Sell - Markets MojoMarket news · 23 May 2026, 10:30 am
Epigral Ltd is Rated Sell Markets Mojo
Corporate actions
Events
- board MeetingsQuarterly Results
- annual General MeetingAGM
- dividendRs.5.0000 per share(50%)Final Dividend
- annual General MeetingPOM
- board MeetingsAudited Results & Final Dividend
- board MeetingsQuarterly Results
- board MeetingsQuarterly Results
- board MeetingsQuarterly Results & Fund Raising
Rusaka Markets Community
Discussion and sentiment for Epigral
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.
Checking your Rusaka Markets account…
Company profile
Business information
What the company does
Epigral Limited is an India-based manufacturer of essential chemicals. The Company is engaged in the manufacturing and selling of chemicals, including derivatives and specialty chemicals. It operates under two businesses, Chlor-Alkali and Derivatives and Speciality chemicals, which relate to the manufacturing of Chlor-Alkali & its Derivatives. Chlor-Alkali is an industrial process that offers Sodium Hypochlorite, Hydrogen Gas, Caustic Soda Lye, Caustic Soda Flakes, and Liquid Chlorine. The Company offers a diverse portfolio of products, including chlorinated polyvinyl chloride (CPVC) Resin, CPVC Compound, Chlorotoluenes Value Chain, Epichlorohydrin, Chloromethanes, Hydrogen Peroxide, Caustic Soda, Chlorine, Hydrogen, and Caustic Potash. The Company caters to a range of industries such as refineries, paper and pulp, fluoropolymers, soaps & detergents, textiles, dyes & pigment, pharmaceuticals, agrochemicals, paints and coating, refrigerant gas, electronics, water treatment, and others.
Company facts
- Industry
- Chemical Manufacturing
- Sector
- Chemical Manufacturing
- NSE Code
- EPIGRAL
- BSE Code
- 543332
Questions
Stock FAQ
What is the symbol and ISIN of Epigral?
Epigral has the symbol EPIGRAL and ISIN - INE071N01016.
What is the current price of Epigral?
Epigral is currently trading at INR 1,098.30.
What are the year high and year low of Epigral?
Epigral has a year high of INR 1,946.05 and a year low of INR 806.20.
What is the market capitalization of Epigral?
Epigral has a market capitalization of INR 4,649.98 crore.
What is the P/E ratio of Epigral?
Epigral has a P/E ratio of 10.08.
What is the dividend yield of Epigral?
Epigral has a dividend yield of 0.45%.
How is the financial performance of Epigral based on revenue, net income, and EPS?
Epigral has revenue of INR 2,527.18 crore, net income of INR 331.97 crore, and EPS of INR 62.82.
What is the book value of Epigral?
Epigral has a book value of NA.
What is the debt-to-equity ratio of Epigral?
Epigral has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Epigral?
Epigral has a price-to-book ratio of NA and a price-to-sales ratio of 1.84.
Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.